Wix.com (WIX) Expands Equity Buyback Plan by US$200 Million

Wix.com (WIX) experienced a notable rise in its share price with a 36% increase over the past month, coinciding with significant developments within the company. The launch of the CookieYes app on the Wix App Market on August 19, focusing on compliance with global privacy regulations, highlighted Wix's ongoing efforts to enhance its platform's offerings. Furthermore, the company's decision to boost its equity buyback plan by $200 million indicates a strong commitment to rewarding shareholders. These initiatives complemented broader market movements, as major indices like the S&P 500 and Nasdaq reached all-time highs, suggesting a synergistic effect on Wix's recent stock performance.

You should learn about the 2 risks we've spotted with Wix.com.

WIX Revenue & Expenses Breakdown as at Sep 2025
WIX Revenue & Expenses Breakdown as at Sep 2025

This technology could replace computers: discover the 23 stocks are working to make quantum computing a reality.

Wix.com's recent initiatives, such as the CookieYes app launch and an enhanced equity buyback plan, could play a substantial role in shaping the company's narrative. These developments align with the company's goal of boosting user growth and retention through AI-driven enhancements, which could potentially lead to better monetization and margin expansion. Over the past three years, Wix's total return surged 129.99%, which highlights its robust performance in the period.

In comparison to the broader market over the past year, Wix underperformed the US IT industry, which presents a competitive challenge moving forward. However, the company's strategic moves, such as AI adoption and Base44 integration, may offer pathways to enhanced revenue growth and margin improvement, supporting the positive future analyst expectations. As of now, Wix's current share price of $167.04, while impressive, remains below the consensus analyst price target of $206.09 by approximately 23.38%, suggesting room for potential upside if the company's strategies effectively increase earnings and revenue growth as anticipated by analysts.

Click here to discover the nuances of Wix.com with our detailed analytical financial health report.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Wix.com might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:WIX

Wix.com

Operates a cloud-based web development platform for registered users and creators in the United States, Europe, Israel, and internationally.

Undervalued with reasonable growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
VTIX logo
Lou_Basenese on Virtuix Holdings ·

From a “Shark Tank” Snub to an Air Force “Yes”: Why Virtuix at $3.50 May Be the Market’sMost Mispriced AI Story

Fair Value:US$7.551.2% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75034.9% undervalued
22 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$56053.9% undervalued
49 users have followed this narrative
2 users have commented on this narrative
27 users have liked this narrative
TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2782.0% undervalued
17 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative

Updated Narratives

AN
AnimalDoctorKwon
RCKT logo
AnimalDoctorKwon on Rocket Pharmaceuticals ·

The Structural Disconnect Between Market Valuation and Operational Maturity

Fair Value:US$1066.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
AKBA logo
AnimalDoctorKwon on Akebia Therapeutics ·

Vafseo and the Future of Renal Anemia Treatment – Akebia’s Vision for a $5B Kidney Disease Portfolio

Fair Value:US$77.2998.6% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
MBIO logo
AnimalDoctorKwon on Mustang Bio ·

A CAR-T Therapy Pipeline with Complete Remission (CR) Data Priced as a Negative Asset???

Fair Value:US$1.861.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7444.6% undervalued
67 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9638.3% undervalued
61 users have followed this narrative
9 users have commented on this narrative
18 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17057.1% undervalued
51 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative